Literature DB >> 17150172

Triclosan.

Lauren Campbell1, Matthew J Zirwas.   

Abstract

Triclosan is a common antibacterial chemical currently in widespread use in household and health care-related products. Triclosan was first introduced in 1965 and has been marketed as cloxifenol, Irgasan CH 3565, and Irgasan DP 300. Its most common use is in antimicrobial hand soaps, but in the United States it can also be found in consumer products such as liquid dishwashing soaps, deodorants, and toothpastes. The concentrations used in products in the United States typically range from 0.15 to 0.3%. While allergy to triclosan-based products is uncommon, several cases of contact dermatitis secondary to triclosan have been reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150172

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  5 in total

1.  Triclosan-induced modification of unsaturated fatty acid metabolism and growth in Pseudomonas aeruginosa PAO1.

Authors:  James W Bullard; Franklin R Champlin; Janna Burkus; Sarah Y Millar; Robert S Conrad
Journal:  Curr Microbiol       Date:  2010-09-26       Impact factor: 2.188

Review 2.  Triclosan-coated sutures and surgical site infection in abdominal surgery: the TRISTAN review, meta-analysis and trial sequential analysis.

Authors:  N A Henriksen; E B Deerenberg; L Venclauskas; R H Fortelny; J M Garcia-Alamino; M Miserez; F E Muysoms
Journal:  Hernia       Date:  2017-10-17       Impact factor: 4.739

3.  Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins.

Authors:  Takehiko Mima; Swati Joshi; Margarita Gomez-Escalada; Herbert P Schweizer
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

4.  The effect of triclosan coated sutures on rate of surgical site infection after hip and knee replacement: a protocol for a double-blind randomised controlled trial.

Authors:  Andrew P Sprowson; Cyrus D Jensen; Nick Parsons; Paul Partington; Kevin Emmerson; Ian Carluke; Seif Asaad; Roland Pratt; Scott Muller; Mike R Reed
Journal:  BMC Musculoskelet Disord       Date:  2014-07-14       Impact factor: 2.362

5.  The Identification of Multidrug-Resistant Microorganisms including Bergeyella zoohelcum Acquired from the Skin/Prosthetic Interface of Amputees and Their Susceptibility to Medihoney™ and Garlic Extract (Allicin).

Authors:  Ruby Harsent; Joshua Macleod; Richard S Rowlands; Paul M Smith; Neil Rushmere; James Blaxland
Journal:  Microorganisms       Date:  2022-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.